Active Wound Care Market

The report "Active Wound Care Market by Product Type (Biological Skin Substitutes (Human donor, Animal derived), Biosynthetic Skin Substitutes, Topical Agents), Wound Type (Diabetic Foot, Venous Leg Ulcers, Pressure Ulcers, Burns) & End User - Global Forecast to 2031", is projected to grow from USD 3.19 billion in 2026 and to reach USD 4.50 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.

Browse 250 market data Tables and 150 Figures spread through 350 Pages and in-depth TOC on "Active Wound Care Market by Product Type (Biological Skin Substitutes (Human donor, Animal derived), Biosynthetic Skin Substitutes, Topical Agents), Wound Type (Diabetic Foot, Venous Leg Ulcers, Pressure Ulcers, Burns) & End User - Global Forecast to 2031"
View detailed Table of Content here -  https://www.marketsandmarkets.com/Market-Reports/wound-care-biologic-market-259878425.html

The global active wound care market is growing steadily, driven by the rising prevalence of chronic and difficult-to-heal wounds, the increasing incidence of diabetes and vascular disorders, and the growing adoption of regenerative and tissue-repair technologies. The increasing use of biological skin substitutes, biosynthetic and synthetic skin substitutes, extracellular matrix-based products, collagen-based products, and growth factor-based therapies is supporting market expansion. Growing emphasis on accelerating wound closure, reducing complications and amputations, and improving clinical outcomes in chronic, surgical, traumatic, and burn wounds is further increasing the adoption of active wound care products across hospitals, specialty wound care centers, and outpatient settings.

Biological skin substitutes accounted for the largest share of the global active wound care market, by product type, in 2025.

Based on product type, the active wound care market is segmented into biological skin substitutes; biosynthetic/synthetic skin substitutes; topical agents, including growth factor- and cytokine-based agents and others; and other active wound care products, including collagen-based products. In 2025, biological skin substitutes accounted for the largest share, supported by their increasing use in chronic and complex wounds, growing clinical evidence supporting tissue regeneration, and the availability of a broad range of human donor tissue-derived and animal-derived products. Biological skin substitutes provide extracellular matrix structures and, depending on the product, viable cellular or biologically active components that support tissue repair and wound closure. Their increasing utilization in diabetic foot ulcers, venous leg ulcers, pressure injuries, surgical wounds, burns, and other difficult-to-heal wounds continues to support the segment's leading market position.

Chronic wounds accounted for the largest share of the active wound care market, by wound type, in 2025.

Based on wound type, the market is segmented into chronic wounds and acute wounds. In 2025, chronic wounds accounted for the largest share, primarily due to their prolonged treatment duration, high recurrence rates, and increasing prevalence among aging and diabetic populations. Rising cases of diabetic foot ulcers, venous insufficiency, pressure injuries, peripheral vascular disease, and associated wound-healing complications are increasing demand for regenerative and biologically active wound care products.

Hospitals accounted for the largest share of the active wound care market, by end user, in 2025.

Based on end user, the market is segmented into hospitals; wound care centers and specialty clinics, including burn centers and trauma centers; ambulatory surgical centers; home healthcare settings; and other end users. In 2025, hospitals accounted for the largest share because they play a central role in managing severe and complex chronic wounds, surgical and dehisced wounds, burns, traumatic injuries, and patients requiring multidisciplinary wound care. Hospitals also perform a substantial number of debridement, reconstructive, grafting, and other surgical procedures in which advanced wound matrices and tissue substitutes may be used. Availability of wound care specialists, surgeons, multidisciplinary clinical teams, and access to advanced treatment technologies further supports the segment's dominant position.

North America accounted for the largest regional share of the global active wound care market in 2025.

The active wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America accounted for the largest share, supported by the high prevalence of diabetes and chronic wounds, established wound care infrastructure, widespread availability of advanced regenerative products, and the strong presence of leading active wound care manufacturers. The region also benefits from a well-developed network of hospitals, outpatient wound care centers, podiatry practices, and specialty clinics, along with comparatively greater adoption of cellular and tissue-based products and other advanced wound-healing technologies.

Europe represents a significant market, supported by its aging population, substantial burden of diabetes and vascular diseases, established wound management practices, and increasing adoption of advanced tissue-repair products. Asia Pacific is expected to register the fastest growth during the forecast period due to the expanding diabetic population, improving healthcare infrastructure, increasing awareness of advanced wound management, rising healthcare expenditure, and greater availability of regenerative wound care products. Latin America and the Middle East & Africa are also expected to expand as specialist wound care infrastructure develops, and access to advanced treatments improves.

Key players in the active wound care market include Smith+Nephew plc (UK), Organogenesis Holdings Inc. (US), MIMEDX Group, Inc. (US), Integra LifeSciences Holdings Corporation (US), Coloplast A/S (Denmark), ConvaTec Group plc (UK), Solventum Corporation (US), AROA Biosurgery Limited (New Zealand), PolyNovo Limited (Australia), AVITA Medical, Inc. (US), Stryker Corporation (US), Tissue Regenix Group plc (UK), URGO Group (France), and Anika Therapeutics, Inc. (US).

Don’t miss out on business opportunities in Wound Care Biologics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com